APA (7th ed.) Citation

S, N. M., K, S. N., M, H. H. A. F., M, F. I., M, A. M. M., Udo, B., & Ashraf, F. S. PEG-PLGA core–shell nanoparticles for the controlled delivery of picoplatin–hydroxypropyl β-cyclodextrin inclusion complex in triple-negative breast cancer: In vitro and in vivo study. De Gruyter.

Chicago Style (17th ed.) Citation

S, Nafie Mohamed, Sedky Nada K, Hassan Hatem A. F. M, Fawzy Iten M, Abdelhady Manal M. M, Bakowsky Udo, and Fahmy Sherif Ashraf. PEG-PLGA Core–shell Nanoparticles for the Controlled Delivery of Picoplatin–hydroxypropyl β-cyclodextrin Inclusion Complex in Triple-negative Breast Cancer: In Vitro and in Vivo Study. De Gruyter.

MLA (9th ed.) Citation

S, Nafie Mohamed, et al. PEG-PLGA Core–shell Nanoparticles for the Controlled Delivery of Picoplatin–hydroxypropyl β-cyclodextrin Inclusion Complex in Triple-negative Breast Cancer: In Vitro and in Vivo Study. De Gruyter.